Journal of International Obstetrics and Gynecology ›› 2013, Vol. 40 ›› Issue (5): 470-471.

• 论著 • Previous Articles     Next Articles

Expression and Clinical Significance of MicroRNA-210 in Ovarian Cancer

BAO Liu-ping,ZHONG Jian-xin,ZHANG Wei   

  1. Department of Obstetrics and Gynecology,Xiangshui Hospital of Jiangsu,Xiangshui County 224600,Jiangsu Province,China(BAO Liu-ping);Department of Obstetrics and Gynecology,Affiliated Hospital of Nantong University,Nantong 226001,Jiangsu Province,China(ZHONG Jian-xin);PLA 157 Hospital,Shenyang 110045,China(ZHANG Wei)
  • Received:1900-01-01 Revised:1900-01-01 Published:2013-10-15 Online:2013-10-15

Abstract: Objective:Detection the expression of miR-210 and investigation its roles in epithelial ovarian cancer(EOC). Methods:Poly(A)-RT-qPCR was used to detect the expression of miR-210 in epithelial ovarian cancers and benign epithelial ovarian cysts and normal ovarian tissues. Results:miR-210 in ovarian cancer group was lower than that of benign ovarian tumors and normal ovarian group,significant difference among the three groups(F=893.213,P=0.000). With the progress of the clinical staging of ovarian cancer tissues and tissue differentiation,miR-210 expression there has a downward trend. Conclusions:Our data suggest that miR-210 expressed lowerly in EOC,it might play an important role as an anti-oncogene in the genesis and development of epithelial ovarian cancer. It is bound with lymphatic metastasis,stages of ovarian cancer and tissus grading.

Key words: Ovarian neoplasms, MicroRNAs, Reverse transcriptase polymerase chain reaction, Genes, tumor suppressor